Variable expression of platelet-derived growth factor family proteins in acute lung injury - PubMed (original) (raw)
Variable expression of platelet-derived growth factor family proteins in acute lung injury
J Walsh et al. Am J Respir Cell Mol Biol. 1993 Dec.
Abstract
During acute lung injury, there is an outpouring of growth factors into the alveolar space that drive local repair and fibrosis. During the remodeling that follows the instillation of bleomycin via the trachea into the adult rat, at least two platelet-derived growth factor (PDGF)-like peptides are released sequentially into lung lining fluid. Groups of four to five animals were killed at 3, 6, 15, and 26 days after exposure to bleomycin and lungs lavaged with isotonic saline. PDGF-like peptides in epithelial lining fluid (ELF) were partially purified by cation exchange chromatography and concentrated. Isolated peptides were analyzed by immunoblotting to determine their molecular weight and immunologic identity. Western blots were probed with polyclonal antibodies to PDGF-BB and PDGF-AA. PDGF-like peptides of two distinct size classes (38-40 kD and 29 kD) were present in alveolar fluid from all rats with lung injury induced by bleomycin. No PDGF-like peptides were found in comparably prepared ELF from control animals. The 38-40 kD peptide was detected only with anti-PDGF-BB antibody; the 29 kD peptide was detected only with anti-PDGF-AA antibody. The presence of these two peptides varied independently with time after exposure to bleomycin. The 38-40 kD peptide was at peak levels at 3 to 6 days. In contrast, the 29 kD peptide was present at all times following injury but with far less variation over time. In parallel with these immunoassays for PDGF-like molecules, there was abundant growth-promoting activity for fibroblasts present in concentrated ELF during the course of injury.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and -BB isoforms secreted by rat alveolar macrophages.
Bonner JC, Osornio-Vargas AR, Badgett A, Brody AR. Bonner JC, et al. Am J Respir Cell Mol Biol. 1991 Dec;5(6):539-47. doi: 10.1165/ajrcmb/5.6.539. Am J Respir Cell Mol Biol. 1991. PMID: 1958381 - Platelet-derived growth factor AA and AB dimers are present in normal human epithelial lining fluid.
Allam M, Martinet N, Gallati H, Vaillant P, Hosang M, Martinet Y. Allam M, et al. Eur Respir J. 1993 Sep;6(8):1162-8. Eur Respir J. 1993. PMID: 8224131 - Chrysotile asbestos stimulates platelet-derived growth factor-AA production by rat lung fibroblasts in vitro: evidence for an autocrine loop.
Lasky JA, Coin PG, Lindroos PM, Ostrowski LE, Brody AR, Bonner JC. Lasky JA, et al. Am J Respir Cell Mol Biol. 1995 Feb;12(2):162-70. doi: 10.1165/ajrcmb.12.2.7865215. Am J Respir Cell Mol Biol. 1995. PMID: 7865215 - Pathogenesis of fibrosis in acute lung injury.
Bitterman PB. Bitterman PB. Am J Med. 1992 Jun 22;92(6A):39S-43S. doi: 10.1016/0002-9343(92)90606-c. Am J Med. 1992. PMID: 1621743 Review. - Platelet-derived growth factor produced by pulmonary cells.
Brody AR, Bonner JC. Brody AR, et al. Chest. 1991 Mar;99(3 Suppl):50S-52S. doi: 10.1378/chest.99.3_supplement.50s. Chest. 1991. PMID: 1997273 Review. No abstract available.
Cited by
- Pulmonary fibrosis: pathogenesis and therapeutic strategies.
Wang J, Li K, Hao D, Li X, Zhu Y, Yu H, Chen H. Wang J, et al. MedComm (2020). 2024 Sep 23;5(10):e744. doi: 10.1002/mco2.744. eCollection 2024 Oct. MedComm (2020). 2024. PMID: 39314887 Free PMC article. Review. - Tissue Inhibitor of Matrix Metalloproteinases-1 (TIMP-1) and Pulmonary Involvement in COVID-19 Pneumonia.
Zingaropoli MA, Latronico T, Pasculli P, Masci GM, Merz R, Ciccone F, Dominelli F, Del Borgo C, Lichtner M, Iafrate F, Galardo G, Pugliese F, Panebianco V, Ricci P, Catalano C, Ciardi MR, Liuzzi GM, Mastroianni CM. Zingaropoli MA, et al. Biomolecules. 2023 Jun 26;13(7):1040. doi: 10.3390/biom13071040. Biomolecules. 2023. PMID: 37509076 Free PMC article. - Targeting Growth Factor and Cytokine Pathways to Treat Idiopathic Pulmonary Fibrosis.
Ma H, Liu S, Li S, Xia Y. Ma H, et al. Front Pharmacol. 2022 Jun 3;13:918771. doi: 10.3389/fphar.2022.918771. eCollection 2022. Front Pharmacol. 2022. PMID: 35721111 Free PMC article. Review. - Inhibition of the Proliferation of Human Lung Fibroblasts by Prostacyclin Receptor Agonists is Linked to a Sustained cAMP Signal in the Nucleus.
Roberts MJ, May LT, Keen AC, Liu B, Lam T, Charlton SJ, Rosethorne EM, Halls ML. Roberts MJ, et al. Front Pharmacol. 2021 Apr 29;12:669227. doi: 10.3389/fphar.2021.669227. eCollection 2021. Front Pharmacol. 2021. PMID: 33995100 Free PMC article. - Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib.
Takekoshi D, Matsui Y, Akutsu T, Nishioka A, Kiritani A, Okuda K, Watanabe J, Miyagawa H, Utsumi H, Hashimoto M, Wakui H, Minagawa S, Hara H, Numata T, Noda Y, Makishima R, Ikegami M, Kawabata Y, Araya J, Kuwano K. Takekoshi D, et al. Intern Med. 2020 Sep 15;59(18):2297-2300. doi: 10.2169/internalmedicine.4714-20. Epub 2020 Jun 15. Intern Med. 2020. PMID: 32536651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources